Jaguar Health, Inc. entered into agreements on December 9 and 11, 2025, exchanging shares of common stock and warrants for Series M Preferred Stock held by Iliad Research and Trading. The total exchanged included 440,000 shares of common stock and 1,609,372 warrants, with the preferred stock subsequently cancelled.